Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04747834 · ClinicalTrials.gov registry record · NA

Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery

A NA study of Cataract, sponsored by Carl Zeiss Meditec.

Completed
Registry status
NA
Development phase
100
Enrollment target
3
Study locations

NCT04747834 is a NA study of Cataract that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 100 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (56% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04747834, a NA study of Cataract, has completed, sponsored by Carl Zeiss Meditec.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this research study is to evaluate the clinical outcomes of the use of low-energy segment removal with a micro-interventional irrigation/aspiration port (MICOR-304) to evacuate the lens prior to intraocular lens insertion in subjects undergoing routine cataract surgery.

Conditions Studied

Interventions

  • DEVICE MICOR-304

Study Locations (3)

Alabama

  • Young H. Choi Eye Surgery Center - Vestavia Hills

Florida

  • Argus Research at Cape Coral Eye Center - Cape Coral

Minnesota

  • Chu Vision Institute - Bloomington

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-01-06
Est. Completion 2022-01-24
Phase NA

Sponsor

Carl Zeiss Meditec

18 total trials

What the Registry Record Tells You About NCT04747834

The ClinicalTrials.gov registry entry for NCT04747834 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (56% lower). The listed sponsor is Carl Zeiss Meditec, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which MICOR-304 is the first listed.

NCT04747834 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Alabama, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT04747834 about?

NCT04747834 is a clinical study titled "Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery". The purpose of this research study is to evaluate the clinical outcomes of the use of low-energy segment removal with a micro-interventional irrigation/aspiration port (MICOR-304) to evacuate the lens prior to intraocular lens insertion in subjects undergoing routine cataract surgery.

What is the current status of trial NCT04747834?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2021-01-06. Estimated completion is 2022-01-24.

What conditions does trial NCT04747834 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT04747834?

The interventions under investigation include: MICOR-304 (DEVICE).

Who is sponsoring clinical trial NCT04747834?

This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04747834 being conducted?

This trial has 3 study locations across Alabama, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.